BIOXYTRAN, INC.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $138.7K

Liabilities Breakdown FY2024

Total Liabilities: $1.9M